Sign inJoin waitlistJoin the waitlist

SF

Salman Fazal

Director · Allegheny Health Network Medical Education Consortium

Credentials: · · · · · ·

History

DREXEL UNIVERSITY
Present

Hematology and Medical Oncology
2003–2006
Internal Medicine
2000–2003
Doctor of Medicine
1996–2000

Research

Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial
Blood · 2020 · 248 citations
Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey
BMC Cancer · 2016 · 170 citations
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover,…
The Lancet Haematology · 2024 · 85 citations

Yazan Samhouri
12 papers · 11 as a resident
John Lister
7 papers
CK
Cyrus Khan
6 papers · 2 as a fellow
Urwat Vusqa
5 papers
AD
Amy DeZern
4 papers
HS
Hira Shaikh
4 papers · 4 as a fellow
PA
Palash Asawa
4 papers · 4 as a fellow
Santhosh Sadashiv
4 papers
Carole Miller
3 papers
Elizabeth Griffiths
3 papers
Eunice Wang
3 papers
Joachim Deeg
3 papers

Clinical trials

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Site PI · Recruiting · Phase 1, Phase 2
Sumitomo Pharma America, Inc.
2022–2027